Longeveron LGVN
NASDAQ LGVN
$3.30 +0.46 (+16.20%)
At close: Nov 11, 2026 · 4:00 PM EST

Longeveron (LGVN) Non Operating Interest Expenses (2020 - 2022)

Updated

Longeveron (LGVN) recorded Non Operating Interest Expenses of $1.4 million in Q4 2022, compared with $1,000 a year earlier.

Analysis

Longeveron (LGVN) Non Operating Interest Expenses (2020 - 2022) Analysis & Trends

Starting with Q3 2020, Longeveron's Non Operating Interest Expenses history includes 6 quarters.

  • Across earlier years, Non Operating Interest Expenses came in at $4,000 in FY2021 (-42.9%) and $7,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 217.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -477.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 269.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Longeveron 8.60 Mn -31.21 Mn 182,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.40 Mn
Jun 30, 2022 2,000.00
Dec 31, 2021 1,000.00
Sep 30, 2021 1,000.00
Jun 30, 2021 2,000.00
Dec 31, 2020 3,000.00
Sep 30, 2020 4,000.00
API Access

Longeveron Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=LGVN&period=max&api_key=YOUR_API_KEY